0.00
price down icon100.00%   -9.81
 
loading
前日終値:
$9.81
開ける:
$0
24時間の取引高:
0
Relative Volume:
0.00
時価総額:
$47.48M
収益:
-
当期純損益:
$-168.86M
株価収益率:
0.00
EPS:
-1.68
ネットキャッシュフロー:
$-125.29M
1週間 パフォーマンス:
-100.00%
1か月 パフォーマンス:
-100.00%
6か月 パフォーマンス:
-100.00%
1年 パフォーマンス:
-100.00%
1日の値動き範囲:
Value
$0.00
$0.00
1週間の範囲:
Value
$0.00
$0.00
52週間の値動き範囲:
Value
$0.00
$24.15

Allovir Inc Stock (ALVR) Company Profile

Name
名前
Allovir Inc
Name
セクター
Healthcare (1174)
Name
電話
(617) 433-2605
Name
住所
1100 WINTER STREET, WALTHAM
Name
職員
6
Name
Twitter
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
ALVR's Discussions on Twitter

ALVR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ALVR
Allovir Inc
0.00 47.48M 0 -168.86M -125.29M -1.68
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Allovir Inc Stock (ALVR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2023-12-26 ダウングレード BofA Securities Buy → Underperform
2023-12-22 ダウングレード JP Morgan Overweight → Underweight
2023-12-22 ダウングレード Leerink Partners Outperform → Market Perform
2023-12-22 ダウングレード Piper Sandler Overweight → Neutral
2023-08-18 開始されました BofA Securities Buy
2021-10-19 再開されました Morgan Stanley Overweight
2020-08-24 開始されました JP Morgan Overweight
2020-08-24 開始されました Morgan Stanley Overweight
2020-08-24 開始されました SVB Leerink Outperform
すべてを表示

Allovir Inc (ALVR) 最新ニュース

pulisher
Jun 17, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Investors to Connect - ACCESS Newswire

Jun 17, 2025
pulisher
Jun 17, 2025

Allovir (NASDAQ:KLRS) Rating Increased to Hold at Wall Street Zen - Defense World

Jun 17, 2025
pulisher
Jun 16, 2025

Deadline to Claim Your Payout from the AlloVir Settlement Is in 2 Months - TradingView

Jun 16, 2025
pulisher
Jun 15, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages AlloVir Inc. (ALVR) Stockholders to Inquire about Securities Investigation - ACCESS Newswire

Jun 15, 2025
pulisher
Jun 13, 2025

AlloVir, Inc. (NASDAQ:ALVR) Stake Lowered by Two Sigma Investments LP - Defense World

Jun 13, 2025
pulisher
Jun 10, 2025

AlloVir Inc. (ALVR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 10, 2025
pulisher
Jun 10, 2025

Caribou Biosciences (NASDAQ:CRBU) versus AlloVir (NASDAQ:ALVR) Critical Contrast - Defense World

Jun 10, 2025
pulisher
Jun 09, 2025

Squarepoint Ops LLC Invests $142,000 in AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Allovir (NASDAQ:KLRS) Cut to Sell at Wall Street Zen - Defense World

Jun 09, 2025
pulisher
Jun 09, 2025

Jane Street Group LLC Buys 39,808 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AlloVir Inc. (ALVR) And Encourages Stockholders to Reach Out - ACCESS Newswire

Jun 08, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Sells 11,800 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 08, 2025
pulisher
Jun 05, 2025

Bronstein, Gewirtz & Grossman, LLC Is Investigating AlloVir Inc. (ALVR) And Encourages Stockholders to Connect - ACCESS Newswire

Jun 05, 2025
pulisher
Jun 05, 2025

Bernstein Liebhard LLP Announces Proposed Class Action Settlement on Behalf of Purchasers of AlloVir, Inc. Securities - TradingView

Jun 05, 2025
pulisher
Jun 05, 2025

Millennium Management LLC Sells 251,018 Shares of AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

Wall Street Zen Upgrades Allovir (NASDAQ:KLRS) to Hold - MarketBeat

Jun 05, 2025
pulisher
Jun 05, 2025

BNP Paribas Financial Markets Acquires New Holdings in AlloVir, Inc. (NASDAQ:ALVR) - Defense World

Jun 05, 2025
pulisher
Jun 03, 2025

AlloVir Inc. (ALVR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Jun 03, 2025
pulisher
Jun 01, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against AlloVir Inc. (ALVR) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Jun 01, 2025
pulisher
Jun 01, 2025

Allovir (NASDAQ:KLRS) Upgraded to “Hold” at Wall Street Zen - Defense World

Jun 01, 2025
pulisher
May 29, 2025

Bronstein, Gewirtz & Grossman, LLC Encourages AlloVir Inc. (ALVR) Investors to Inquire about Securities Investigation - ACCESS Newswire

May 29, 2025
pulisher
May 29, 2025

Kalaris: Phase 1 Trial for TH103 Advances Following AlloVir Merger and Other Important Updates - TradingView

May 29, 2025
pulisher
May 26, 2025

Allovir (NASDAQ:KLRS) Rating Lowered to Sell at Wall Street Zen - Defense World

May 26, 2025
pulisher
May 19, 2025

Deadline to Claim Your Payout from the AlloVir $ALVR Settlement Is in 3 Months - TradingView

May 19, 2025
pulisher
May 14, 2025

AlloVir ($ALVR) Is Paying a Settlement to Investors — Here’s How to Get Your Share - TradingView

May 14, 2025
pulisher
May 14, 2025

Kalaris Therapeutics, Inc. SEC 10-Q Report - TradingView

May 14, 2025
pulisher
May 14, 2025

Kalaris Reports First Quarter 2025 Financial Results and Provides Business Highlights - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Kalaris Eyes Breakthrough in AMD Treatment: Phase 1 Trial Progress and $101M War Chest Revealed in Q1 Earnings - Stock Titan

May 14, 2025
pulisher
May 10, 2025

Shareholders that lost money on AlloVir, Inc.(ALVR) Urged to Join Class ActionContact Levi & Korsinsky to Learn More - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir LawsuitALVR - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

AlloVir, Inc. Sued for Securities Law ViolationsInvestors Should Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your RightsALVR - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Lost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking RecoveryContact Levi & Korsinsky - ACCESS Newswire

May 10, 2025
pulisher
May 10, 2025

Shareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class ActionALVR - ACCESS Newswire

May 10, 2025
pulisher
May 07, 2025

Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire

May 07, 2025
pulisher
May 07, 2025

Renaissance Technologies LLC Trims Stock Position in AlloVir, Inc. (NASDAQ:ALVR) - Defense World

May 07, 2025
pulisher
May 02, 2025

DEADLINE ALERT: Bernstein Liebhard LLP Reminds AlloVir, Inc. Investors of Upcoming Deadline - ACCESS Newswire

May 02, 2025
pulisher
Apr 28, 2025

SHAREHOLDER ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineALVR - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 28, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 28, 2025
pulisher
Apr 28, 2025

Levi & Korsinsky Notifies AlloVir, Inc.(ALVR) Investors of a Class Action Lawsuit and Upcoming Deadline - marketscreener.com

Apr 28, 2025
pulisher
Apr 24, 2025

Halper Sadeh LLP, AlloVir, Inc., Avid Bioservices, Inc., EMCORE Corporation - The Bradford Era

Apr 24, 2025
pulisher
Apr 19, 2025

Halper Sadeh LLP, Aerovate Therapeutics, Inc., Staffing 360 Solutions, Inc., Allovir - The Bradford Era

Apr 19, 2025
pulisher
Apr 09, 2025

AlloVir Announces FDA Clearance of Investigational New Drug Application for ALVR106, an Allogeneic, Off-The-Shelf, Multi-Virus Specific T Cell Therapy Targeting Four Devastating Respiratory Viruses - marketscreener.com

Apr 09, 2025
pulisher
Apr 08, 2025

William Blair Initiates Kalaris Therapeutics With Outperform Rating - MarketScreener

Apr 08, 2025
pulisher
Apr 06, 2025

(ALVR) Technical Data - news.stocktradersdaily.com

Apr 06, 2025
pulisher
Apr 05, 2025

Kalaris Therapeutics appoints new board chair By Investing.com - Investing.com Canada

Apr 05, 2025
pulisher
Apr 04, 2025

The Gross Law Firm Notifies Shareholders of AlloVir, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of March 19, 2024(NASDAQ: ALVR) - MarketScreener

Apr 04, 2025
pulisher
Apr 04, 2025

Kalaris Therapeutics appoints new board chair - Investing.com India

Apr 04, 2025
pulisher
Apr 04, 2025

Kalaris Expands Board of Directors Appointing Leone Patterson as Chair of Audit Committee - The Manila Times

Apr 04, 2025
pulisher
Apr 04, 2025

Kalaris Expands Board Of Directors Appointing Leone Patterson As Chair Of Audit Committee - MarketScreener

Apr 04, 2025

Allovir Inc (ALVR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
大文字化:     |  ボリューム (24 時間):